A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trial
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (12), 1969-1983
- https://doi.org/10.1016/s0149-2918(01)80150-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical Success and Quality of Life With Brimonidine 0.2% or Timolol 0.5% Used Twice Daily in Glaucoma or Ocular Hypertension: A Randomized Clinical TrialJournal of Glaucoma, 2000
- Pharmacological Therapy for GlaucomaDrugs, 2000
- Antiglaucoma medications: A review of safety and tolerability issues related to their useClinical Therapeutics, 2000
- Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: Year-three resultsClinical Therapeutics, 2000
- The role of medical therapy in the rank order of glaucoma treatmentCurrent Opinion in Opthalmology, 1999
- Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patientsAmerican Journal of Ophthalmology, 1999
- Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertensionOphthalmology, 1998
- A 1-Year Study of Brimonidine Twice Daily in Glaucoma and Ocular HypertensionArchives of Ophthalmology (1950), 1997
- Preclinical evaluation of brimonidineSurvey of Ophthalmology, 1996
- Effects of Brimonidine on Aqueous Humor Dynamics in Human EyesArchives of Ophthalmology (1950), 1995